Join our ImmunoCommunity and share your story!
"When a man is going through prostate cancer, what better person to talk to than another prostate cancer survivor?"
Like many men, Isadore Wayne Sr. first found out he had prostate cancer when blood work from a routine physical exam showed that his PSA levels were elevated. A biopsy confirmed what the blood test suggested: stage 3 prostate cancer.
At 46 years old, in 2002, Isadore had just retired from a 25-year career as a delivery driver for UPS. He was looking forward to watching his two school-aged boys grow up. The last thing he expected was to become a cancer patient. He was overwhelmed, angry, and felt alone.
After consulting with doctors, Isadore decided to have a prostatectomy, which was performed at the Mayo Clinic in Rochester, MN. Upon returning home, while adjusting to his new identity as a cancer survivor, Isadore was surprised to learn that there were few support options available to him in the St. Louis, MO, area.
A few years later, at a charity event, he met a fellow prostate cancer survivor named Mellve Shahid, who shared his frustration with the lack of support for prostate cancer survivors. In 2007, the two men teamed up and started The Empowerment Network, a support and educational group for prostate cancer survivors and their families in the St. Louis metropolitan area.
Around that same time, Isadore’s PSA began to rise again, so he went on a hormone treatment called leuprolide (Eligard®), designed to block androgen production. Then, in 2011, he was treated with sipuleucel-T (Provenge®), a dendritic cell-based therapeutic cancer vaccine that is meant to enlist the immune system in the fight against prostate cancer.
Isadore is now 57 and still going strong. When TheAnswertoCancer (TheA2C) caught up with him, he was busy planning his wedding with his fiancée, Martha.
Others may benefit from hearing your experience and treatment journey.
In the world of cancer immunotherapy, Antoni Ribas, M.D., Ph.D., has earned a reputation for being both a world...
By the time Joseph Rick considered going on a clinical trial, he had already bought a grave. Thirty-two weeks of...
Michael Rose was diagnosed with stage 4 Diffuse large B–cell lymphoma (DLBCL), an aggressive form of non...
Join the ImmunoCommunity to access an important resource for all things related to cancer immunotherapy. Connect with others who have shared experiences and learn about new treatment options.
To continue to find the answers to cancer, it takes funding for research. Donate to the Cancer Research Institute today to help us continue to search for answers.